Avalon GloboCare Corp.
ALBTOther · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | |
|---|---|---|---|---|---|---|
| Revenue | $0 | $1.3M | $1.3M | $1.2M | $1.4M | $1.4M |
| Operating income | −$7.6M | −$4.8M | −$15.8M | −$8.8M | −$8.8M | −$12.5M |
| Net income | $94,453 | −$7.9M | −$16.7M | −$11.9M | −$9.1M | −$12.7M |
| Total assets | $23.4M | $21.0M | $20.6M | $19.8M | $10.2M | $10.4M |
| Total liabilities | $14.2M | $13.9M | $13.2M | $8.6M | $7.2M | $6.2M |
| Equity | $9.2M | $7.1M | $7.4M | $11.2M | $3.1M | $4.1M |
| EPS (diluted) | $-5.64 | $-8.44 | $-23.80 | $-1.28 | $-1.07 | — |
| Shares out. | 1.7M | 11.1M | 10.2M | 88.6M | 0 | 78.1M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- —
- Net margin
- —
- Return on equity
- 1.0%
- Return on assets
- 0.4%
- Return on capital (ROCE)
- −82.0%
- Liabilities / assets
- 60.6%
- Debt / equity
- 1.54×
- Book value / share
- $5.59
- Revenue growth (YoY)
- −100.0%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Altman Z″ (distress)
- -19.80distress
- Accruals / assets
- 20.0%high accruals
- Piotroski F-Score
- 4/8mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast. What these scores mean →
Signs
● 2 severe● 3 warning● 0 good- Altman Z″ in the distress zone
- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Revenue declined year-over-year
- Negative operating cash flow
- High accruals — earnings-quality risk
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Qmissed a reporting deadline ↗Aug 14, 2024
- NT 10-Qmissed a reporting deadline ↗May 15, 2024
- NT 10-Kmissed a reporting deadline ↗Apr 1, 2024
- NT 10-Qmissed a reporting deadline ↗May 16, 2023
- NT 10-Kmissed a reporting deadline ↗Mar 30, 2020
- NT 10-Qmissed a reporting deadline ↗Aug 15, 2019
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| Lu WenzhaoDirector | Aug 5, 2022 | Grant | 448,718 | $0.78 |
| Lu WenzhaoDirector | Jul 18, 2022 | Grant | 4.4M | $0.65 |
| Lu WenzhaoDirector | Apr 1, 2020 | Buy | 645,161 | $1.55 |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 306,891 | 1.0 | -25.8% |
| Apr 30, 2026 | 413,675 | 1.0 | -55.4% |
| Apr 15, 2026 | 926,778 | 1.0 | +31.1% |
| Mar 31, 2026 | 706,973 | 1.0 | -21.4% |
| Mar 13, 2026 | 899,445 | 1.0 | -81.5% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Other material eventApr 21, 2026
- Delisting / listing-standard noticeApr 17, 2026
- Item 5.08Apr 2, 2026
- Other material eventApr 1, 2026
- Shareholder voteMar 30, 2026
- Director / officer changeMar 10, 2026
- Entered a material agreement · Unregistered equity sale · Other material eventMar 2, 2026
- Regulation FD disclosureFeb 26, 2026
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- SCHEDULE 13GMay 15, 2026
- 10-QQUARTERLY REPORTMay 11, 2026
- 8-K/AAMENDMENT NO. 1 TO FORM 8-KApr 21, 2026
- 8-KCURRENT REPORTApr 21, 2026
- EFFECTApr 20, 2026
- 424B3PROSPECTUSApr 20, 2026
- ARSFORM ARSApr 17, 2026
- DEFA14ADEFINITIVE ADDITIONAL MATERIALSApr 17, 2026
- DEF 14ADEFINITIVE PROXY STATEMENTApr 17, 2026
- 8-KCURRENT REPORTApr 17, 2026
- CORRESPApr 16, 2026
- UPLOADApr 14, 2026
- S-1REGISTRATION STATEMENTApr 8, 2026
- RWWITHDRAWAL REQUESTApr 8, 2026
- PRE 14APRELIMINARY PROXY STATEMENTApr 2, 2026
Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.